Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

international animal health products pty ltd - bifidobacterium bifidum; enterococcus faecium; lactobacillus delbrueckii subspecies bulgaricus; lactobacillus acidophilus; lactobacillus plantarum; lactobacillus rhamnosus; streptococcus salivarius subspecies thermophilus - oral powder, pre-mix - bifidobacterium bifidum biological-organism active 0.0 p; enterococcus faecium biological-organism active 0.0 p; lactobacillus delbrueckii subspecies bulgaricus biological-organism active 0.0 p; lactobacillus acidophilus biological-organism active 0.0 p; lactobacillus plantarum biological-organism active 0.0 p; lactobacillus rhamnosus biological-organism active 0.0 p; streptococcus salivarius subspecies thermophilus biological-organism active 0.0 p - nutrition & metabolism - animal | birds | cage birds | calf | cat | cattle | dog | dog - puppy | goat | goat kid | horse | horse foal | kitten | lamb | p - establishment of gut microflora | intestinal dysfunction | productivity improvements | promote animal growth | reduced mortality | re-establishment of gut microflora | feed conversion | finishing | following antibiotic use | growth promotion | growth rate | improving feed efficiency | increasing rate of weight gain | liveweight gain | post-antibiotic therapy

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

dox-al australia pty ltd - tiamulin fumarate - oral powder, pre-mix - tiamulin fumarate antibiotic active 980.0 g/kg - antibiotic & related - pigs | poultry non laying | boar | gilt | piglet | sow | swine - chronic respiratory disease | mycoplasma gallisepticum | mycoplasma hyopneumoniae | serpulina (treponema) hyodysenteriae | swine dysentery | chronic respiratory disease (c | infectious sinusitis | reduction of lung lesions | respiratory disease | swine enzootic pneumonia

Nigeria - English - NAFDAC (National Agency for Food and Drugs Administration and Control)

flamulina velutipes 245mg, selenium accumulated yeast 5mg

United States - English - NLM (National Library of Medicine)

rebel distributors corp. - retapamulin (unii: 4mg6o8991r) (retapamulin - unii:4mg6o8991r) - retapamulin 10 mg in 1 g - altabax is indicated for use in adults and pediatric patients aged 9 months and older for the topical treatment of impetigo (up to 100 cm2 in total area in adults or 2% total body surface area in pediatric patients aged 9 months or older) due to staphylococcus aureus (methicillin-susceptible isolates only) or streptococcus pyogenes [see clinical studies (14)] . to reduce the development of drug-resistant bacteria and maintain the effectiveness of altabax and other antibacterial drugs, altabax should none. 8.1 pregnancy pregnancy category b . effects on embryo-fetal development were assessed in pregnant rats given 50, 150, or 450 mg/kg/day by oral gavage on days 6 to 17 postcoitus. maternal toxicity (decreased body weight gain and food consumption) and developmental toxicity (decreased fetal body weight and delayed skeletal ossification) were evident at doses ≥150 mg/kg/day. there were no treatment-related malformations observed in fetal rats. retapamulin was given as a continuous intravenous infusion to pre

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

range pharma sdn. bhd. - tiamulin hydrogen fumarate -

United States - English - NLM (National Library of Medicine)

nabriva therapeutics us, inc. - lefamulin acetate (unii: hdn0b924x4) (lefamulin - unii:21904a5386) - xenleta is indicated for the treatment of adults with community-acquired bacterial pneumonia (cabp) caused by the following susceptible microorganisms: streptococcus pneumoniae , staphylococcus aureus (methicillin-susceptible isolates), haemophilus influenzae , legionella pneumophila , mycoplasma pneumoniae , and chlamydophila pneumoniae . to reduce the development of drug-resistant bacteria and maintain the effectiveness of xenleta and other antibacterial drugs, xenleta should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. xenleta is contraindicated in patients with known hypersensitivity to lefamulin, pleuromutilin class drugs, or any of the components of xenleta. xenleta table

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

v.m.d. sa-nv - tiamuline 100 mg/ml - solution for injection - 10 % - tiamulin 100 mg/ml - tiamulin - pig

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

alltech lienert australia pty ltd - tiamulin fumarate - oral granules, pellets - tiamulin fumarate antibiotic active 25.0 g/kg - nutrition & metabolism - pigs | poultry non laying | boar | gilt | piglet | sow | swine - antibiotic - anti-infective | pneumonia | swine dysentery | abrasions | abscesses | airsacculitis | antiseptic | avian mycoplasmas | bacterial pneumonia | blackhead | body odours | bowed tendons | broad spectrum | burns | coccidiosis | coliform complex | conjunctivitis | cowpox | cracks | crusts | dandruff | dermatological disorders | dermatosis | dry skin | dysentery | eczema | endometritis | enteric diseases | enzootic pneumonia | feed efficiency | fungal infections | girth galls | infections | inflammed pads | itching | keratolytic | lacerations | mastitis | mycoplasmas | odours | open wounds | otitis | pruritis | queensland itch | respiratory disease | saddle rash | salmonellosis | scabs | scaly skin | sheath rot | skin irritations | sores | swine dysentery | teat cracking | teat infections | topical infections | udder sores | weight gain | wire cuts | wounds